Published in Acad Med on October 01, 2001
The disavowed curriculum: understanding student's reasoning in professionally challenging situations. J Gen Intern Med (2003) 1.06
Critical events in the lives of interns. J Gen Intern Med (2008) 0.92
Clinical uncertainty: helping our learners. Can Fam Physician (2011) 0.78
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 15.54
Accessing genetic information with high-density DNA arrays. Science (1996) 13.89
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics (1999) 7.56
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med (1998) 5.54
Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med (1986) 5.17
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem (1999) 3.72
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med (1989) 2.69
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res (1999) 2.59
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med (1989) 2.52
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med (2000) 2.44
An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature (1997) 2.42
Context, conflict, and resolution: a new conceptual framework for evaluating professionalism. Acad Med (2000) 2.39
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A (1990) 2.18
Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb (1994) 2.05
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest (1996) 2.03
Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem (1986) 2.02
Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest (1993) 1.99
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol (2000) 1.92
Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A (1994) 1.91
An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci U S A (1985) 1.90
A study of lower-limb mechanics during stair-climbing. J Bone Joint Surg Am (1980) 1.89
Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest (1990) 1.84
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med (1988) 1.71
Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S. J Cell Biol (1986) 1.68
Risk factors associated with human cystic echinococcosis in Florida, Uruguay: results of a mass screening study using ultrasound and serology. Am J Trop Med Hyg (1998) 1.68
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1994) 1.62
Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem (1995) 1.58
Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A (1998) 1.57
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest (1998) 1.51
Management of hypertension in twelve Oxfordshire general practices. J R Coll Gen Pract (1986) 1.43
Naive neutrophils and xenotransplantation. Lancet (1996) 1.41
beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol (2000) 1.40
A certain art of uncertainty: case presentation and the development of professional identity. Soc Sci Med (2003) 1.39
Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med (1995) 1.37
Transcriptional and post-transcriptional control of plastid mRNA levels in higher plants. Trends Genet (1988) 1.34
RAGE: a novel cellular receptor for advanced glycation end products. Diabetes (1996) 1.34
Inhibition by colchicine and by vinblastine of acetylcholine-induced catecholamine release from the adrenal gland: an anticholinergic action, not an effect upon microtubules. Mol Pharmacol (1972) 1.31
An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate. Lancet (1975) 1.27
Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med (1989) 1.24
Hypoxia induces glucose transporter expression in endothelial cells. Am J Physiol (1992) 1.22
Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci (2001) 1.20
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood (1993) 1.20
Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun (1989) 1.19
Activation of coagulation releases endothelial cell mitogens. J Cell Biol (1986) 1.16
Initiation codon mutations in the Chlamydomonas chloroplast petD gene result in temperature-sensitive photosynthetic growth. EMBO J (1993) 1.15
Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med (1999) 1.13
Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am J Physiol (1992) 1.12
Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest (2000) 1.10
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem (1990) 1.09
Asymmetric processing of coding ends and the effect of coding end nucleotide composition on V(D)J recombination. Immunity (1995) 1.09
The predictive relationship between serum IgE levels at birth and subsequent incidences of lower respiratory illnesses and eczema in infants. Am Rev Respir Dis (1992) 1.08
'Talking the talk': school and workplace genre tension in clerkship case presentations. Med Educ (2003) 1.08
Xiphopagus conjoined twins: a 300-year review of the obstetric, morphopathologic, neonatal, and surgical parameters. Am J Obstet Gynecol (1980) 1.07
Teaching students to break bad news. Am J Surg (2001) 1.07
Two color hybridization analysis using high density oligonucleotide arrays and energy transfer dyes. Nucleic Acids Res (1998) 1.05
The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem (1994) 1.05
Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep (2000) 1.05
Protein kinase C-beta and oxygen deprivation. A novel Egr-1-dependent pathway for fibrin deposition in hypoxemic vasculature. J Biol Chem (2000) 1.03
Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity. J Clin Invest (1985) 1.03
Relationship of total serum IgE levels in cord and 9-month sera of infants. Clin Exp Allergy (1991) 1.02
Oral manifestations of Darier's disease. J Oral Surg (1976) 1.00
Cloning of a novel RNA binding polypeptide (RA301) induced by hypoxia/reoxygenation. J Biol Chem (1995) 1.00
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc Res (2000) 0.99
Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J Biol Chem (1997) 0.98
Principles of the surgical approach in human liver cystic echinococcosis. Acta Trop (1997) 0.97
EMAP II: a modulator of neovascularization in the developing lung. Am J Physiol (1999) 0.97
Regulation of plastid rDNA transcription by interaction of CDF2 with two different RNA polymerases. EMBO J (2000) 0.96
Student professionalism: a CDIM commentary. Am J Med (1999) 0.95
Arrays of arrays for high-throughput gene expression profiling. Genome Res (2001) 0.95
Hypoxia induces endothelial cell synthesis of membrane-associated proteins. Proc Natl Acad Sci U S A (1991) 0.94
150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoprotein. J Clin Invest (1996) 0.93
Infant intermodal speech perception is a left-hemisphere function. Science (1983) 0.93
RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. Restor Neurol Neurosci (1998) 0.92
Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. J Clin Invest (1991) 0.92
A view to regressive autism through home movies. Is early development really normal? Acta Psychiatr Scand (2006) 0.91
Sclerosing peritonitis. Possible early diagnosis by computerized tomography of the abdomen. Am J Nephrol (1988) 0.90
Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. J Immunol (1993) 0.90
CD14: a bridge between innate immunity and adaptive IgE responses. J Endotoxin Res (2001) 0.90
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide. Biochim Biophys Acta (2000) 0.90
Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood (1992) 0.89
Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation. Am J Pathol (1997) 0.88
The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrol Dial Transplant (1996) 0.87
Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest (1993) 0.85
The effect of small infarcts and carotid endarterectomy on postoperative psychologic test performance. J Surg Res (1980) 0.85
Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response. Behring Inst Mitt (1993) 0.85
Directionality of dental trait frequency between human second deciduous and first permanent molars. Arch Oral Biol (1987) 0.84
High-speed photography of excimer laser ablation of the cornea. Arch Ophthalmol (1987) 0.84
Calcified subdural haematomas associated with arrested hydrocephalus--late sequelae of shunt operation in infancy. Eur J Radiol (1985) 0.84
Faulty sternotomy and complications after median sternotomy. J Thorac Cardiovasc Surg (1988) 0.83
Multiplex capillary denaturing high-performance liquid chromatography with laser-induced fluorescence detection. Biotechniques (2001) 0.83
Penetrating duodenal trauma. J Trauma (1984) 0.83
Replacement of Pro109 by His in TlpA, a thioredoxin-like protein from Bradyrhizobium japonicum, alters its redox properties but not its in vivo functions. FEBS Lett (1997) 0.83